AstraZeneca vaccine controversies in the media: Theorizing about the mediatization of ignorance in the context of the COVID-19 vaccination campaign

A Sendra, S Torkkola, J Parviainen - Health Communication, 2024 - Taylor & Francis
As is the case in other situations of deep uncertainty, the unknowns related to the COVID-19
pandemic have aroused a great deal of attention in the media. Drawing insights both from …

[HTML][HTML] Effects of hydroxychloroquine and its metabolites in patients with connective tissue diseases

D Eryavuz Onmaz, D Tezcan, S Abusoglu… - …, 2021 - Springer
Hydroxychloroquine has attracted attention in the treatment of COVID-19. Many conflicting
findings have been reported regarding the efficacy and safety of this drug, which has been …

The third booster vaccination dose against COVID-19: Indications for circulating SARS-CoV-2 variants

F Rahimi, AT Bezmin Abadi - Future Virology, 2021 - Taylor & Francis
One-and-half years after its discovery in Wuhan, China, COVID-19 has turned into a global
public-health catastrophe [1–3]. By 13 September 2021, unfortunately 225,707,678 …

Covid-19 Pandemic, Hydroxychloroquine, and Healthcare System in Turkey

E Kayaalp Jurich - The Legitimacy of Healthcare and Public Health …, 2023 - Springer
During the Covid-19 pandemic, certain drugs were touted as 'miracle cures'. One was
hydroxychloroquine (HCQ), an anti-malarial drug, which was used for the Covid-19 …

AstraZeneca Vaccine Controversies in the Media: Theorizing About the Mediatization of Ignorance in the Context of the COVID-19 Vaccination Campaign

A Sendra Toset, S Torkkola, J Parviainen - 2024 - trepo.tuni.fi
As is the case in other situations of deep uncertainty, the unknowns related to the COVID-19
pandemic have aroused a great deal of attention in the media. Drawing insights both from …

Retrospektive Evaluierung einer Hydroxychloroquin Therapiestudie bei hospitalisierten COVID-19 Patienten

S Weber - 2022 - tobias-lib.ub.uni-tuebingen.de
COVID-19 verursachte bis Dezember 2021 weltweit den Tod von 5, 1 Millionen Menschen.
Der Bedarf nach einer effektiven Therapie gegen COVID-19 war und ist weiterhin groß …